Literature DB >> 2154968

Subcellular distribution of alpha 2-adrenergic receptors, pertussis-toxin substrate and adenylate cyclase in human platelets.

M A Zamorski1, J C Ferraro, R R Neubig.   

Abstract

The subcellular distribution of the alpha 2-adrenergic receptor, pertussis-toxin substrates (Gi, the inhibitory G-protein) and adenylate cyclase was determined in human platelets. The alpha 2-adrenergic receptor and pertussis-toxin substrate activity codistribute with surface membranes identified by a novel fluorescent-lectin method. The platelet granule fractions did not contain detectable Gi. Only 2-4% of the total pertussis-toxin substrate activity appears in soluble fractions, and this amount was not increased upon addition of purified beta gamma units or after pretreatment of platelets with adrenaline. There is no evidence for compartmentation of the alpha 2-adrenergic receptor or Gi to account for the low-affinity component of agonist binding to the alpha 2-adrenergic receptor in human platelet membranes. Translocation of Gi from plasma membrane to platelet cytosol or granules does not appear to play any significant role in the mechanism of alpha 2-receptor-mediated platelet activation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2154968      PMCID: PMC1133698          DOI: 10.1042/bj2650755

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  47 in total

1.  Subcellular particles of human platelets. A biochemical and electron microscopic study with particular reference to the influence of fractionation techniques.

Authors:  H J Day; H Holmsen; T Hovig
Journal:  Scand J Haematol Suppl       Date:  1969

2.  Subcellular localization of Gi alpha in human neutrophils.

Authors:  D Rotrosen; J I Gallin; A M Spiegel; H L Malech
Journal:  J Biol Chem       Date:  1988-08-05       Impact factor: 5.157

3.  Mechanism of agonist and antagonist binding to alpha 2 adrenergic receptors: evidence for a precoupled receptor-guanine nucleotide protein complex.

Authors:  R R Neubig; R D Gantzos; W J Thomsen
Journal:  Biochemistry       Date:  1988-04-05       Impact factor: 3.162

4.  A small multigene family encodes Gi signal-transduction proteins.

Authors:  C R Beals; C B Wilson; R M Perlmutter
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

5.  Myristoylated alpha subunits of guanine nucleotide-binding regulatory proteins.

Authors:  J E Buss; S M Mumby; P J Casey; A G Gilman; B M Sefton
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

Review 6.  Receptors linked to inhibition of adenylate cyclase: additional signaling mechanisms.

Authors:  L E Limbird
Journal:  FASEB J       Date:  1988-08       Impact factor: 5.191

Review 7.  Mechanisms of action of calcium-mobilizing agonists: some variations on a young theme.

Authors:  J H Exton
Journal:  FASEB J       Date:  1988-08       Impact factor: 5.191

Review 8.  Evidence for involvement of guanine nucleotide-binding regulatory proteins in the activation of phospholipases by hormones.

Authors:  J N Fain; M A Wallace; R J Wojcikiewicz
Journal:  FASEB J       Date:  1988-07       Impact factor: 5.191

9.  Subcellular localization and quantitation of the major neutrophil pertussis toxin substrate, Gn.

Authors:  G M Bokoch; K Bickford; B P Bohl
Journal:  J Cell Biol       Date:  1988-06       Impact factor: 10.539

10.  Lateral segregation of neutrophil chemotactic receptors into actin- and fodrin-rich plasma membrane microdomains depleted in guanyl nucleotide regulatory proteins.

Authors:  A J Jesaitis; G M Bokoch; J O Tolley; R A Allen
Journal:  J Cell Biol       Date:  1988-09       Impact factor: 10.539

View more
  1 in total

1.  Mastoparan promotes exocytosis and increases intracellular cyclic AMP in human platelets. Evidence for the existence of a Ge-like mechanism of secretion.

Authors:  C P Wheeler-Jones; T Saermark; V V Kakkar; K S Authi
Journal:  Biochem J       Date:  1992-01-15       Impact factor: 3.857

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.